Ein Blog der ZHAW Zürcher Hochschule für Angewandte Wissenschaften
The Innovative Medicines Initiative (IMI) is launching the last Calls for proposals under the IMI2 programme, with topics on tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, and more. Deadline for submission is 29 Sep 2020. Further Information Schlagwörter: IMI, IMI2 programme, innovative Medicines initiative
The Innovative Medicines Initiative (IMI) has launched its 20th Call for proposals on 21 January 2020. It is a standard, two-stage call for proposals. Deadline for stage one is 21 April 2020. The new call includes the following topics: Schlagwörter: IMI, innovative Medicines initiative
The Innovative Medicines Initiative (IMI) has published draft topic texts for the next call for proposals, planned for 21 January 2020. IMI2 – Call 20 Schlagwörter: IMI, innovative Medicines initiative
IMI2 has just published the indicative topics and draft topic texts for the next calls. The following topics are currently under consideration for inclusion in future IMI calls for proposals: Schlagwörter: IMI, innovative Medicines initiative
Swiss researchers and organisations can now fully participate in the whole Horizon 2020 programme, including IMI, on equal terms with entities from EU Member States and other associated countries. Switzerland became fully associated to Horizon 2020 on 1 January 2017 following the country’s ratification, on 16 December 2016, of the Protocol extending the EU-Switzerland Free […]